Radius Health reports analysis from phase 3 ACTIVE trial and data from preclinical studies
Radius Health reported a post-hoc analysis of Phase 3 data from different patient populations included in the ACTIVE trial, and results from preclinical studies of abaloparatide and its effect on the development and growth of osteoclasts and on bone resorption. March 23, 2019